Showing 941 - 960 results of 1,915 for search '"cancer"', query time: 0.05s Refine Results
  1. 941
  2. 942
  3. 943
  4. 944
  5. 945
  6. 946
  7. 947
  8. 948
  9. 949
  10. 950
  11. 951
  12. 952
  13. 953
  14. 954
  15. 955
  16. 956
  17. 957
  18. 958
  19. 959
  20. 960

    Economic evaluation of encorafenib with cetuximab in patients with BRAF V600E-mutant metastatic colorectal cancer in France: a cost-effectiveness analysis using data from the BEACON CRC randomised controlled trial by David Malka, Philippe Laramée, Mondher Toumi, Jean-Baptiste Trouiller, Bérengère Macabeo, Andrew Poll, Dan Howard, Andy Buckland, Marine Sivignon, Emilie Clay, Emmanuelle Samalin

    Published 2022-11-01
    “…Objective The BEACON CRC randomised controlled trial (NCT02928224) in BRAF-mutant metastatic colorectal cancer (mCRC) patients showed improved overall survival for the combination treatment of encorafenib (BRAF inhibitor) with cetuximab (EGFR inhibitor) compared with cetuximab with chemotherapy (FOLFIRI (folinic acid, fluorouracil and irinotecan) or irinotecan). …”
    Get full text
    Article